The Valley Desk

NCT01747486 · Interventional trial

Dose Optimization Trial of CD19 Redirected Autologous T Cells

Overall registry status Completed

Phase 2

Conditions Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov